1. Home
  2. MDXG vs FOR Comparison

MDXG vs FOR Comparison

Compare MDXG & FOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
    SELLHOLDBUYas of 18 hours ago
  • FOR
    SELLHOLDBUYas of 18 hours ago
  • Stock Information
  • Founded
  • MDXG 2006
  • FOR 2005
  • Country
  • MDXG United States
  • FOR United States
  • Employees
  • MDXG N/A
  • FOR N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • FOR Real Estate
  • Sector
  • MDXG Health Care
  • FOR Finance
  • Exchange
  • MDXG Nasdaq
  • FOR Nasdaq
  • Market Cap
  • MDXG 1.2B
  • FOR N/A
  • IPO Year
  • MDXG N/A
  • FOR 2007
  • Fundamental
  • Price
  • MDXG $7.60
  • FOR $21.14
  • Analyst Decision
  • MDXG Strong Buy
  • FOR Strong Buy
  • Analyst Count
  • MDXG 3
  • FOR 3
  • Target Price
  • MDXG $12.00
  • FOR $34.00
  • AVG Volume (30 Days)
  • MDXG 535.9K
  • FOR 215.4K
  • Earning Date
  • MDXG 04-29-2025
  • FOR 04-17-2025
  • Dividend Yield
  • MDXG N/A
  • FOR N/A
  • EPS Growth
  • MDXG N/A
  • FOR N/A
  • EPS
  • MDXG 0.28
  • FOR 3.56
  • Revenue
  • MDXG $348,879,000.00
  • FOR $1,453,900,000.00
  • Revenue This Year
  • MDXG $10.09
  • FOR $10.37
  • Revenue Next Year
  • MDXG $11.77
  • FOR $11.16
  • P/E Ratio
  • MDXG $26.93
  • FOR $5.93
  • Revenue Growth
  • MDXG 8.52
  • FOR N/A
  • 52 Week Low
  • MDXG $5.47
  • FOR $20.70
  • 52 Week High
  • MDXG $10.14
  • FOR $40.86
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 38.98
  • FOR 39.68
  • Support Level
  • MDXG $7.84
  • FOR $21.70
  • Resistance Level
  • MDXG $8.12
  • FOR $22.28
  • Average True Range (ATR)
  • MDXG 0.24
  • FOR 0.60
  • MACD
  • MDXG -0.02
  • FOR 0.01
  • Stochastic Oscillator
  • MDXG 24.05
  • FOR 19.73

Stock Price Comparison Chart: MDXG vs FOR

MDXG
FOR
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025051015202530354045MDXG VS FOR

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use